0001140361-17-018048.txt : 20170503 0001140361-17-018048.hdr.sgml : 20170503 20170503125509 ACCESSION NUMBER: 0001140361-17-018048 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20170501 FILED AS OF DATE: 20170503 DATE AS OF CHANGE: 20170503 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: NEVRO CORP CENTRAL INDEX KEY: 0001444380 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 562568057 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1800 BRIDGE PARKWAY CITY: REDWOOD CITY STATE: CA ZIP: 94065 BUSINESS PHONE: 650-251-0005 MAIL ADDRESS: STREET 1: 1800 BRIDGE PARKWAY CITY: REDWOOD CITY STATE: CA ZIP: 94065 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Elghandour Rami CENTRAL INDEX KEY: 0001613689 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36715 FILM NUMBER: 17808280 MAIL ADDRESS: STREET 1: 15 BARCELONA CIR CITY: REDWOOD CITY STATE: CA ZIP: 94065 4 1 doc1.xml FORM 4 X0306 4 2017-05-01 0 0001444380 NEVRO CORP NVRO 0001613689 Elghandour Rami C/O NEVRO CORP. 1800 BRIDGE PARKWAY REDWOOD CITY CA 94065 1 1 0 0 President & CEO Common Stock 2017-05-01 4 M 0 10000 3.60 A 105224 D Common Stock 2017-05-01 4 S 0 10000 95.0302 D 95224 D Stock Option (right to buy) 3.60 2017-05-01 4 M 0 10000 0.00 D 2023-05-14 Common Stock 10000 65051 D Includes 94,739 restricted stock units. The sale was effected pursuant to the Reporting Person's Rule 10b5-1 trading plan. The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $95.00 to $95.36, inclusive. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. The option, representing the right to purchase 88,207 shares of the Issuer's common stock, vests and becomes exercisable in respect to 1/48th of the original number of shares subject to the option on each monthly anniversary measured from May 15, 2013 (the "Vesting Commencement Date"), such that 100% of the shares underlying the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date, subject to the Reporting Person's continued service to the Issuer. /s/ Andrew Galligan, as Attorney-in-Fact for Rami Elghandour 2017-05-03